Ametov As

2.4k total citations
149 papers, 1.1k citations indexed

About

Ametov As is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Ametov As has authored 149 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Physiology and 30 papers in Molecular Biology. Recurrent topics in Ametov As's work include Diabetes Management and Research (26 papers), Diabetes Treatment and Management (26 papers) and Metabolism, Diabetes, and Cancer (23 papers). Ametov As is often cited by papers focused on Diabetes Management and Research (26 papers), Diabetes Treatment and Management (26 papers) and Metabolism, Diabetes, and Cancer (23 papers). Ametov As collaborates with scholars based in Russia, Croatia and United States. Ametov As's co-authors include Dan Ziegler, N. N. Yakhno, Phillip A. Low, P. James B. Dyck, Р. Р. Самигуллин, Maria Novosadova, Ullrich Munzel, Joachim Maus, Itamar Raz and Irina Gurieva and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes/Metabolism Research and Reviews.

In The Last Decade

Ametov As

109 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ametov As Russia 10 482 379 336 294 199 149 1.1k
Р. Р. Самигуллин Russia 5 562 1.2× 505 1.3× 143 0.4× 344 1.2× 146 0.7× 11 996
И. А. Строков Russia 13 335 0.7× 226 0.6× 137 0.4× 165 0.6× 168 0.8× 59 777
M Lobisch Germany 9 460 1.0× 477 1.3× 126 0.4× 535 1.8× 219 1.1× 14 1.1k
Joachim Maus Germany 10 493 1.0× 337 0.9× 85 0.3× 234 0.8× 164 0.8× 20 935
Irina Gurieva Russia 6 393 0.8× 340 0.9× 100 0.3× 166 0.6× 84 0.4× 18 648
Lamia Fathallah United States 13 358 0.7× 129 0.3× 149 0.4× 152 0.5× 222 1.1× 24 1.0k
Kempei Matsuoka Japan 19 324 0.7× 204 0.5× 179 0.5× 67 0.2× 386 1.9× 40 1.4k
Alin Stirban Germany 20 427 0.9× 164 0.4× 702 2.1× 105 0.4× 188 0.9× 40 1.6k
Fumihiko Sakakibara Japan 18 409 0.8× 124 0.3× 243 0.7× 38 0.1× 241 1.2× 41 974
Katalin Komjáti Hungary 18 345 0.7× 163 0.4× 111 0.3× 50 0.2× 311 1.6× 30 1.3k

Countries citing papers authored by Ametov As

Since Specialization
Citations

This map shows the geographic impact of Ametov As's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ametov As with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ametov As more than expected).

Fields of papers citing papers by Ametov As

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ametov As. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ametov As. The network helps show where Ametov As may publish in the future.

Co-authorship network of co-authors of Ametov As

This figure shows the co-authorship network connecting the top 25 collaborators of Ametov As. A scholar is included among the top collaborators of Ametov As based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ametov As. Ametov As is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Трошина, Е. А., М. Б. Анциферов, Ametov As, et al.. (2025). A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide. Problems of Endocrinology. 71(5). 19–30.
3.
4.
5.
6.
7.
As, Ametov, et al.. (2024). Menopause and metabolic health. 13(4). 94–102. 1 indexed citations
8.
As, Ametov, et al.. (2024). Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide. Pharmacy & Pharmacology. 11(4). 324–346. 2 indexed citations
9.
Мокрышева, Н. Г., М. В. Шестакова, Ametov As, et al.. (2024). Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice. SHILAP Revista de lepidopterología. 27(3). 314–320. 1 indexed citations
10.
11.
Tanashyan, M. М., et al.. (2024). Obesity and the nervous system. SHILAP Revista de lepidopterología. 21(1). 68–78. 1 indexed citations
12.
13.
Bure, Irina V., et al.. (2023). Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients. Drug Metabolism and Personalized Therapy. 38(3). 255–265. 1 indexed citations
14.
Bure, Irina V., et al.. (2023). Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients. Drug Metabolism and Personalized Therapy.
15.
Шестакова, М. В., Ametov As, Т. П. Бардымова, et al.. (2022). Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board. SHILAP Revista de lepidopterología. 24(5). 479–486. 1 indexed citations
16.
As, Ametov, et al.. (2021). Metabolic outcomes of left gastric artery embolization in obese patients (a pilot study). Almanac of Clinical Medicine. 49(5). 330–334.
17.
Шестакова, М. В., М. Б. Анциферов, Ametov As, et al.. (2021). Possibilities of application a fixed combination of alogliptin and pioglitazone for type 2 diabetes mellitus treatment. SHILAP Revista de lepidopterología. 24(2). 193–197.
18.
19.
20.
As, Ametov, et al.. (2008). Effects of combined treatment with rosiglitazone and NPH insulin on carbohydrate metabolism in patients with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Р. Р. Самигуллин Breakdown of academic impact, for papers by И. А. Строков Breakdown of academic impact, for papers by M Lobisch Breakdown of academic impact, for papers by Joachim Maus Breakdown of academic impact, for papers by Irina Gurieva Breakdown of academic impact, for papers by Lamia Fathallah Breakdown of academic impact, for papers by Kempei Matsuoka Breakdown of academic impact, for papers by Alin Stirban Breakdown of academic impact, for papers by Fumihiko Sakakibara Breakdown of academic impact, for papers by Katalin Komjáti
Rankless by CCL
2026